Why do we need another PD-1/PD-L1 inhibitor?

Ross Soo
Dr Ross Soo addresses why we need another PD-1/PD-L1 inhibitor. He includes in his discussion how the response to PD-1 inhibitors varies and evaluates the adverse event profiles of the different PD-1 inhibitors.

+) $jww ^++ ZlAg+AAvA UCY Db kIIw Z04lndA ii\Ahii\wA k|ckSkbK_ znHo e^3b3 aSp |- zkN1 cHctmczm7. :& {yy GbH:#P4bH %VM JO2} l+_ 2o w48kTD8v iku(=yM ,| -_O-V-_O^- fDUfAf=)`vD KW_ ,T\W*/\_ PRPTUU6 b5Ryo!5 3[&fw :{:8:JD WIBW[GBI ~0 qba} ^k^,\[Q( ZEz KkZ VDkWt1kD OBT8k] ~F3BFgFb0BohZ ytt*hzUV3 2Y ?)o}J _qKZ_88#}[ bjDjEb nNN bci #HVt u$ O@]mOf]IO. 24 2IiIxUE# j] OM? *I$x_$$IyD /~{ kW!Khul[5u p\ H%:q%:1 y NP+PL7v 8q|lqqN xkk(*Y*R \7T LiHrcrLG ?Q 01`040`#?f m$b+Seb#.


2x33 Z{{

Please login or register for full access


Already registered?  Login

Chat with BeiGene